Nuvectis Pharma, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
NVCT on Nasdaq
Location
1 Bridge Plaza, Suite 275, Fort Lee, NJ

Insiders trading volume in the past year

Nuvectis Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ron Bentsur Chairman & CEO, Director, 10%+ Owner $16.1M +$176K +1.11% Nov 15, 2024
Charles Mosseri 10%+ Owner $12.4M +$309K +2.55% Dec 13, 2024
Shay Shemesh Chief Dev. & Ops. Officer $9.44M +$7.03K +0.07% May 10, 2024
Enrique Poradosu Chief Science & Business Off $7.52M +$13.1K +0.17% Nov 19, 2024
Michael Carson Vice President, Finance $717K -$22.5K -3.04% Jan 3, 2023
Kenneth Hoberman Director $695K Jun 13, 2024
Matthew Kaplan Director $565K Jun 13, 2024
James F. Oliviero III Director $390K Jun 13, 2024
Uri Ben-Or Int. Principal Financial Off. $283K Feb 8, 2022

Recent Insider Transactions by Companies or Individuals for Nuvectis Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.